Novo Nordisk’s Wegovy linked to reduced food noise in real-world studies
NVO•Novo Nordisk presented real-world study results linking Wegovy injections and pills to reduced intrusive food thoughts, with improvements reported over periods of up to six months; the observational studies cannot establish causality.
1. Study findings
Novo Nordisk presented real-world study results at ObesityWeek 2026 linking Wegovy injections and pills to reduced intrusive food thoughts. SIGNAL found reductions within the first month of injections that were sustained through six months, while OCTANE showed reduced food-related thoughts over three months with oral semaglutide; most participants reported treatment improvements. The observational studies suggest potential benefits beyond weight loss but cannot establish causality.
